Survival and clinical features of retinoblastoma;Supervivencia y aspectos clínicos del retinoblastoma

Anales de Pediatria

Volumn 58, Issue 1, 2003, Pages 3-9

  Cerecedo Diaz F ^a   Lopez Aguilara E ^a   Rivera Marquez H ^a   Arias Gomez J ^a   Ramirez Santarita F ^b   Rodriguez Cruz M ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b NONE

Author keywords

Chemotherapy; Retinoblastoma; Survival

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; VINCRISTINE;

AGE DISTRIBUTION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL FEATURE; CYTOGENETICS; EARLY DIAGNOSIS; GEOGRAPHY; HISTOLOGY; HUMAN; INCIDENCE; INFANT; INTRAOCULAR TUMOR; LEUKOKORIA; MAJOR CLINICAL STUDY; MEXICO; PRESCHOOL CHILD; PROGNOSIS; RETINOBLASTOMA; STRABISMUS; VISUAL ACUITY;

EID: 0038745646     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13042236     Document Type: Article

References (39)

1. Hurwitz RL, Shields CL, Shields JA, Chévez BP, Hurwitz MY. Retinoblastoma. En: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology, 4th ed. Philadelphia: Lippincott-Williams, 2002; p. 825-46.
2. Donaldson SS, Egbert PR, Newsham I, Cavenee WK. Retinoblastoma. En: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology, 3th ed. Philadelphia: Lippincott-Raven, 1997; p. 699-715.
3. Gurney J, Smith M, Ross JA. Cancer Among Infants XII. SEER Pediatric Monograph. National Cancer Institute, 1999;149-56. Disponible en: http://www-seer.ims.nci.nih.gov.
4. Saw SM, Tan N, Lee SB, Au Eong KG, Chia KS. Incidence and survival characteristics of retinoblastoma in Singapore. J Pediatr Ophtalmol Strabismus 2000;37:87-93.
5. Finger PT, Czechonska G, Demirci H, Rausen A. Chemotherapy for retinoblastoma: A current topic. Drugs 1999;58:983-96.
6. Salim A, Wiknjosastro GH, Danukusumo D, Barnas B, Zalud I. Fetal retinoblastoma. J Ultrasound Med 1998;17:717-20.
7. Bravo-Ortiz JC, Mendoza-Sánchez HF, Fajardo-Gutiérrez A. Algunas Características epidemiológicas del retinoblastoma en niños residentes del Distrito Federal. Bol Med Hosp Infant Mex 1996;53:234-9.
8. Juárez-Ocaña S, Fajardo-Gutiérrez A. Mortalidad en niños mexicanos menores de 15 años durante el período de 1974-1996. En: Fajardo-Gutiérrez A, editor. Cáncer en el niño. Epidemiología descriptiva, 1th ed. México: Cuéllar, 2002: p. 29-52.
9. Gómez R, Leal-Leal C, Rivera-Luna R, Medina-Esparza A, Martínez-Avalos A, et al. Los Aspectos Epidemiológicos en el retinoblastoma bilateral. Gac Med Mex 1995;131:527-35.
10. Shields CL, Shields JA, Shah P. Retinoblastoma in older children. Ophthalmology 1991;98:395-9.
11. Stahl A, Levy N, Wadzynska T, Sussan JM, Jourdan FD, Saracco JB. The genetics of retinoblastoma. Ann Géńt 1994;37:172-8.
12. Scriver ChR, Beaudet AL, Sly WS, Valle D. Retinoblastoma, in the metabolic and molecular bases of inherited disease. McGraw-Hill, 1995;613.
13. Knudson A. Mutation and Cancer: Statistical Study of Retinoblastoma. Proc Natl Acad Sci 1971;68:820-3.
14. Lee WW, Bookstein R, Hong F, Young LJ, Shew JY, Lee HY. Human retinoblastoma susceptibility gene: Cloning, identification and sequence. Science 1987;235:1394-9.
15. Yunis JJ, Ramsay YN. Retinoblastoma and subband deletion of chromosome 13. Am J Disd Child 1978;132:161-3.
16. Goodrich WD, Lee HW. Molecular charachterization of the retinoblastoma susceptibility gene. BB Acta 1993;1155:43-61.
17. Kodilinye HC. Retinoblastoma in Nigeria. Problems of treatment. Am J Ophthalmol 1967;63:469-81.
18. Goddard AG, Kingston JE, Hungerford JL. Delay diagnosis of retinoblastoma: Risk factors and treatment outcome. Br J Ophtalmol 1999;83:1320-3.
19. Moorhead PS, Nowell PC, Mcllman WJ, Battips DM. Chromosome preparations of leukocytes cultured from human peripheral blood. Exp Cell Res 1960;20:613.
20. Viegas PE, Dutrillaux B. Une methode simple pour obtenir des propases et des prometaphases. Ann Génét 1978;21:122.
21. Seabright M. A rapid banding technique for human chromosomes. Lancet 1971;2:971.
22. Kempter K. Quick preparation of high molecular wight DNA by freezing. TIG 1992;8:226-7.
23. Wright DK, Manos MM. Sample preparation from paraffin embedded tisues. En: Innis MA, Editado por Gelfand MA, Sninsky JJ, White TJ, editors. PCR Protocols: A guide to methods and applications. San Diego: Academic Press, 1990: p. 153-8.
24. Pratt CB. Management of malignant solid tumor in children. Pediatr Clin North Am 1972;19:1141-5.
25. Fajardo-Gutierrez A, Sandoval-Mex A, Mejia-Arangure JM, Rendon-Macias E, Martinez-Garcia MC. Clinical and social factors that affect the time to diagnosis of mexican children with cancer. Med Pediatr Oncol 2002;39:25-31.
26. Erwenne CM, Franco EL. Age and lateness of referral as determinants of extra-ocular retinoblastoma. Ophthalmic Paediatr Genet 1989;10:179-84.
27. Abramsom DH, Frank ChM, Susman M, Whalen MP, Dunkel IJ, Boyd NW. Presenting signs of retinoblastom. J Pediatr 1998;132:505-8.
28. Canzano JC, Handa JT. Utility of pupillary dilation for detecting leukocoria in patients with retinoblastoma. Pediatrics 1999;104:
29. Perales AA, Martínez AA, López CC, et al. Retinoblastoma en el Hospital Infantil de México Federico Gómez. Bol Med Hosp Infant Mex 2000;57(Suppl):S6-S7.
30. Ross G, Lipper EG, Abramson D, Preiser L. The development of young children with retinoblastoma. Arch Pediatr Adolesc Med 2001;155:80-3.
31. Sant M, Capocaccia R, Badioni RV. Survival for retinoblastoma in Europe. Eur J Cancer 2001;37:730-6.
32. Salamanca GF, Luengas F, Antillon F. Genetic and cytogenetic studies in children with retinoblastoma. Cancer Genet Cytogenet 1984;13:129-38.
33. Lohmann D, Brandt B, Hopping W, Passarge E. Horsthemke. The spectrum of RB1 germ-line mutations in hereditary retinoblastoma. Am J Hum Genet 1996;58:940-9.
34. Alonso J, Garcia-Miguel P, Abelairas J, Mendiola M, Sarret E, Vendrell MT, et al. Spectrum of germline RB1 gene mutations in Spanish retinoblastoma patients: Phenotypic and molecular epidemiological implications. Hum Mutat 2001;17:412-22.
35. Blanquet V, Turleau C, Gross SM, Senamaud BC, Doz F, Besmond C. Spectrum of germline mutation in the RB1 gene: A study of 232 patients with hereditary and non hereditary retinoblastoma. Hum Mol Genet 1995;4:383-8.
36. Blanquet V, Turleau C, Gross SM, Goossens M, Besmond C. Identification of germline mutations in the RB1 gene by denaturant gradient gel electrophoresis and polymerase chain reaction direct sequencing. Hum Mol Genet 1993;7:975-9.
37. Brichard B, De Bruycker JJ, De Potter P, Neven B, Vermylen C, Cornu G. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma. Med Pediatr Oncol 2002;38:411-5.
38. Schouten van Meeteren AYN, Moll AC, Imhof SM, Veerman AJP. Chemotherapy for retinoblastoma: An expanding area of clinical research. Med Pediatr Oncol 2002;38:328-38.
39. Hadjistilianou T, Mastrangelo D, De Francesco S, Mazzotta C. Conservative treatment in unilateral retinoblastoma: A preliminary report. Med Pediatr Oncol 2002;38:439-41.